# Ampersand Capital Partners: portfolio, investments and team > Ampersand Capital Partners is a private equity based in United States. 14 investments on record, latest Oct 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/ampersand-capital-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Ampersand Capital Partners Last cheque observed Oct 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Private equity Quiet Seed Series A Series B Digital-health Iiot Advanced Manufacturing Follow Ampersand Capital Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fampersand-capital-partners) Cheques on record **0%** of best year **0** **cheques in 12 months**, 14 on record Since the last cheque **2573** days **00** hrs **00** min **00** sec Median round **$82M** Rounds led **0 of 14** Sole investor **5 rounds** Exits **1 from the portfolio** Mostly in **United States, 100%** Pitch Ampersand Capital Partners ## Ampersand Capital Partners highlights - 01 14 rounds on record - 02 Mostly Venture and Series B: 64% of its rounds - 03 Sole investor in 5 rounds, median $20M - 04 1 exits from the portfolio ## What they do > Ampersand Capital Partners is a life sciences and healthcare-focused private equity firm. From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Digital-health Iiot Advanced Manufacturing - **Based in:** Boston, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **14 appearances** - **2019** 1 round - **Oct** **[Arranta Bio](https://millionrounds.com/company/arranta-bio)** US · FinSMEs **$82M** Sole investor - **2015** 1 round - **Jan** **[CutisPharma](https://millionrounds.com/company/cutispharma)** Growth · US **Undisclosed** Sole investor - **2014** 1 round - **Jan** **[NutraMed](https://millionrounds.com/company/nutramed)** Debt · US **$13M** With 1 other - **2011** 2 rounds - **Apr** **[Nitinol Devices & Components](https://millionrounds.com/company/nitinol-devices-and-components)** Venture · US · nitinol.com **$20M** Sole investor - **Mar** **[Blue Sky Biotech](https://millionrounds.com/company/blue-sky-biotech)** US · prweb.com **Undisclosed** Sole investor - **2010** 1 round - **Mar** **[FirstRain](https://millionrounds.com/company/firstrain)** Venture · US · sec.gov **$7.3M** With 2 others - **2008** 1 round - **Jan** **[FirstRain](https://millionrounds.com/company/firstrain)** Venture · US · venturebeat.com **$14M** With 2 others - **2007** 1 round - **Jun** **[Cequent Pharmaceuticals](https://millionrounds.com/company/cequent-pharmaceuticals)** Series A · US · cequentpharma.com **$9.0M** With 4 others - **2006** 2 rounds - **Nov** **[Magellan Diagnostics](https://millionrounds.com/company/magellan-diagnostics)** Growth · US **$50M** With 6 others - **Apr** **[FirstRain](https://millionrounds.com/company/firstrain)** Venture · US **$19M** With 2 others - **2004** 2 rounds - **Dec** **[ProGene Biomedical](https://millionrounds.com/company/progene-biomedical)** Venture · US **$5.0M** Sole investor - **Jun** **[Endeca](https://millionrounds.com/company/endeca)** Series C · US · allbusiness.com **$15M** With 5 others - **2003** 1 round - **Jul** **[FirstRain](https://millionrounds.com/company/firstrain)** Series B · US **$8.3M** With 3 others - **2001** 1 round - **Nov** **[Endeca](https://millionrounds.com/company/endeca)** Series B · US · news.com **$15M** With 2 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **3 named** DL **Dana L Niles** CCO, Partner and COO i Form ADV HH **Herbert H Hooper** Managing Partner & Managing Member i Form ADV RA **Richard Alan Charpie** Founder & Managing Member i Form ADV We also hold **72** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$3.1B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Ampersand Management LLC - **SEC number:** CRD 161522 Funds on its Form ADV **5** private funds, **$2.8B** in gross assets · filed Aug 2024 - Ampersand 2023 Limited Partnership *Private equity* 164 investors $1.2B - Ampersand 2020 Limited Partnership *Private equity* 99 investors $658M - Ampersand 2018 Limited Partnership *Private equity* 77 investors $447M - Ampersand CF Limited Partnership *Private equity* 76 investors $443M - Ampersand 2014 Limited Partnership *Private equity* 55 investors $7.9M ## What they claim to have backed From their own portfolio page (on their website) **1** of 1 we have independently watched raise [Constantcontact](https://millionrounds.com/company/constant-contact) Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **1 in all** **[Endeca](https://millionrounds.com/company/endeca)** Bought by [Oracle Corporation](https://millionrounds.com/fund/oracle) **Undisclosed** Oct 2011 An exit counts when it came after the firm's first round in the company. From historical deal records. ## Companies it bought Acquisitions by the firm itself **Protein Technologies** **Undisclosed** Jun 2015 **ESA Bioscience** **Undisclosed** May 2004 ## The cheque Seed Series A Series B Median round joined **$82M** the round, not its cheque Alone, median **$20M** Led 0 of 14 rounds **0%** - **Sole investor:** 5 rounds - **Last cheque:** Oct 2019 - **Exits:** 1 from the portfolio Rounds by stage said on their site - Venture *5* - Series B said *2* - Growth said *2* - Series A said *1* - Debt *1* - Seed said *-* - Pre-IPO said *-* Cheques by year Led Joined 2001 2019 Often in the room with - [Diamondhead Ventures](https://millionrounds.com/fund/diamondhead-ventures) 4 - [Oak Investment Partners](https://millionrounds.com/fund/oak-investment-partners) 3 - [Bessemer Venture Partners](https://millionrounds.com/fund/bessemer-venture-partners) 2 - [Nexus Medical Partners](https://millionrounds.com/fund/nexus-medical-partners) 2 - [Venrock](https://millionrounds.com/fund/venrock) 2 **Pitching Ampersand Capital Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Ampersand Capital Partners. A count of rooms they were both in, not a relationship either has claimed. [**Diamondhead Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/diamondhead-ventures)[**Oak Investment Partners** Private equity **3** rounds together](https://millionrounds.com/fund/oak-investment-partners)[**Bessemer Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/bessemer-venture-partners)[**Nexus Medical Partners** VC firm **2** rounds together](https://millionrounds.com/fund/nexus-medical-partners)[**Venrock** VC firm **2** rounds together](https://millionrounds.com/fund/venrock) ## Quick answers about Ampersand Capital Partners ### What does Ampersand Capital Partners invest in? Ampersand Capital Partners invests most often at Venture and Series B (64% of the rounds on record), in sectors such as Digital-health, Iiot and Advanced Manufacturing. ### How active is Ampersand Capital Partners? 14 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2019. ### What has Ampersand Capital Partners invested in recently? Its most recent investments on record: Arranta Bio (Undisclosed round, Oct 2019). ### How big are Ampersand Capital Partners's cheques? The median round it joins is $82M. ### Does Ampersand Capital Partners lead rounds? Rarely, if at all: none of its 14 investments on record names it as the lead. ### Where does Ampersand Capital Partners invest? Most of the companies it backs are in the United States (100%). ### Is Ampersand Capital Partners investing now? No investments in the last 12 months; the latest was in Oct 2019. ### Who does Ampersand Capital Partners invest alongside? Most often Diamondhead Ventures (4 rounds together), Oak Investment Partners (3 rounds together) and Bessemer Venture Partners (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=ampersand-capital-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=ampersand-capital-partners)